Senior Scientist / Project Leader, Clinical Genomics

Overview

The Knowledge Systems Group at Dana-Farber Cancer Institute seeks a Senior Scientist / Project Leader to lead the development of MatchMiner, our open source informatics platform for algorithmically matching cancer patients to precision medicine clinical trials. For complete background on the MatchMiner platform, please refer to our paper on bioRxiv.

We are seeking an exceptional candidate to lead the MatchMiner effort and broaden its impact at DFCI and other cancer centers. This is an exciting, open source platform that has the potential to affect thousands of patients across the U.S., and we need a creative leader, who can take the platform to the next level.

Primary Responsibilities

  • Serve as the primary product and project manager at DFCI for the open source MatchMiner platform.
  • Serve as the primary outreach coordinator for trial investigators and primary oncologists at DFCI.
  • Be the public face of MatchMiner and present the platform at internal stakeholder meetings and at external scientific conferences.
  • Oversee a team of bioinformatics engineers dedicated to the MatchMiner project.
  • Oversee the curation of genomic and other criteria for clinical trials as part of the MatchMiner platform.
  • Develop and oversee a systematic, IRB-approved plan to evaluate the impact of MatchMiner at DFCI
  • Write paper(s) describing the impact of MatchMiner.
  • Develop and coordinate an open source MatchMiner consortium across multiple NCI-designated cancer centers.
  • Write grants and secure long-term funding for the project.

Required Skills & Experiences

  • PhD in cancer biology, cancer genomics, or a related field with a strong clinical / translational cancer focus.
  • Expertise in cancer genomics, and the clinical application of cancer genomics.
  • At least three years of experience managing a cross-functional team of individuals with diverse skill sets.
  • Excellent interpersonal communication and writing skills.
  • Excellent organization skills, including the ability to organize teams.
  • Exceptional attention to detail.
  • Strong leadership skills.
  • Interest in or experience with (agile) software development.

The candidate must also demonstrate outstanding personal initiative, work effectively as part of a team, meet deadlines, and efficiently multitask.

How to Apply

Email a short description of your interest with your CV directly to: Ethan Cerami: cerami AT jimmy.harvard.edu.

About Dana-Farber

Located in Boston, Dana-Farber Cancer Institute brings together world renowned clinicians, innovative researchers and dedicated professionals, allies in the common mission of conquering cancer, HIV/AIDS and related diseases. Combining extremely talented people with the best technologies in a genuinely positive environment, we provide compassionate and comprehensive care to patients of all ages; we conduct research that advances treatment; we educate tomorrow's physician/researchers; we reach out to underserved members of our community; and we work with amazing partners, including other Harvard Medical School-affiliated hospitals.

Equal Employment Opportunity

Dana-Farber Cancer Institute is an equal opportunity employer and affirms the right of every qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other groups as protected by law.

Latest News

  • DFCI to build new Cancer Immunologic Data Commons (CIDC)

    February 14, 2018

    Dana-Farber Cancer Institute (PIs: X. Shirley Liu and Ethan Cerami) was recently selected to build the new NCI Cancer Immuno-Data Commons (CIDC). This is a 5-year multi-institutional effort, and we are excited to get started!

    Read about the award here. And check out our new open positions.

  • cBioPortal awarded NCI Grant

    Sep 11, 2017

    We are happy to report that the cBioPortal for Cancer Genomics was recently awarded a multi-institutional NCI award.